Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0,21%
1 091,51
-2,30
-0,21%
—1 093,811 096,521 100,221 091,51——
SIXC
Communications
SIXC
Communications
SIXC
+0,22%
610,11
+1,34
+0,22%
—608,77608,77612,97608,77——
SIXE
Energy
SIXE
Energy
SIXE
-1,34%
1 237,98
-16,83
-1,34%
—1 254,811 253,011 253,871 226,33——
SIXI
Industrials
SIXI
Industrials
SIXI
-0,93%
1 744,71
-16,40
-0,93%
—1 761,111 764,271 766,881 744,71——
SIXM
Financials
SIXM
Financials
SIXM
-0,37%
640,18
-2,40
-0,37%
—642,58644,87648,48640,18——
SIXR
Staples
SIXR
Staples
SIXR
-0,18%
849,58
-1,55
-0,18%
—851,13855,66858,75845,56——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,23%
217,48
-0,50
-0,23%
—217,98217,98218,65216,88——
SIXT
Technology
SIXT
Technology
SIXT
+1,52%
3 260,69
+48,86
+1,52%
—3 211,833 227,213 268,383 226,55——
SIXU
Utilities
SIXU
Utilities
SIXU
-0,69%
942,45
-6,53
-0,69%
—948,98948,58957,83941,97——
SIXV
Health care
SIXV
Health care
SIXV
-0,52%
1 466,80
-7,72
-0,52%
—1 474,521 479,031 481,041 466,80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,22%
2 397,50
+5,38
+0,22%
—2 392,122 396,952 421,222 382,32——
4559:TYO
Zeria Pharmaceutical Co Ltd
2 132,00 JP¥
-1,25%
(-27,00) 1D
1-май, 15:30:00 GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4559...
Open
2 155 JP¥
High
2 156 JP¥
Low
2 123 JP¥
Mkt. cap
106,85 млд
Avg. vol.
96,12 миң
Volume
54,00 миң
Dividend
2,25%
Quarterly dividend
12 JP¥
Ex dividend date
2025-ж., 29-сен.
P/E ratio
12,94
52-wk high
2 378 JP¥
52-wk low
1 878 JP¥
EPS
165 JP¥
Shares outstanding
50,11 млн
No. of employees
2 миң
News stories
From sources across the web
Profile
Zeria Shinyaku Kōgyō KK is a Japanese drug manufacturer that obtained Tillotts Pharma AG. In 1955, the Japanese Kisaku Ibu, former Yamanouchi Seiyaku executive opened a new pharmaceutical company in Tokyo under the name Zeria Yakushō Kenkyusho. In 1970, this company becomes Zeria Shinyaku Zeria Shinyaku KK. In 1975, it built a new factory in Kumagaya in Saitama prefecture, before the main factory in Tsukuba which was constructed by Takenaka Corporation in 1988. In 2009, the company obtained Switzerland company Tillotts Pharma AG, and began operating internationally through a large network of subsidiaries, It manufactures and sells pharmaceuticals in Sweden, Ireland, UK, Czech Republic, Spain, Germany, France, Italy, Vietnam and Denmark. The drug itself is developed in Switzerland, Tillotts Parma. The company owns a 6.63% share of Asuka Seiyaku, also a pharmaceutical company, other than its subsidiaries. The main shareholder of the company is the company itself, the present president Mitsuhiro Ibu, Mitsubishi UFJ Financial Group, Custody Bank of Japan, Morinaga Milk Industry, SMBC, Mizuho Bank, Risona Bank, Aioi Nissay Dowa Insurance as of March 2023. Wikipedia
About Zeria Pharmaceutical Co Ltd
CEOSachiaki Ibe
Employees1,75 миң
Founded1955-ж., 22-дек.
Headquarters-
SectorPharmaceutical industry
Websitezeria.co.jp
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
2025-ж. мар.
2025-ж. июн.
2025-ж. сен.
2025-ж. дек.
Revenue
22,54 млд
19,49 млд
20,47 млд
24,12 млд
Cost of goods sold
6,05 млд
5,58 млд
5,59 млд
6,38 млд
Cost of revenue
6,05 млд
5,58 млд
5,59 млд
6,38 млд
Research and development expenses
4,11 млд
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4,58 млд
12,39 млд
12,76 млд
12,82 млд
Operating expense
14,54 млд
12,39 млд
12,76 млд
12,82 млд
Total operating expenses
20,59 млд
17,97 млд
18,35 млд
19,19 млд
Operating income
1,95 млд
1,52 млд
2,12 млд
4,93 млд
Other non operating income
-51,00 млн
25,00 млн
-23,00 млн
-81,04 млн
EBT including unusual items
2,16 млд
1,66 млд
994,00 млн
4,63 млд
EBT excluding unusual items
2,18 млд
1,66 млд
994,00 млн
4,63 млд
Income tax expense
397,00 млн
624,00 млн
383,00 млн
795,44 млн
Effective tax rate
18,34%
37,61%
38,53%
-
Other operating expenses
-
-
-
-
Net income
1,71 млд
1,09 млд
647,00 млн
3,82 млд
Net profit margin
7,59%
5,59%
3,16%
-
Earnings per share
-
-
-
-
Interest and investment income
95,00 млн
279,00 млн
30,00 млн
136,71 млн
Interest expense
-114,00 млн
-121,00 млн
-119,00 млн
-123,00 млн
Net interest expenses
-19,00 млн
158,00 млн
-89,00 млн
13,71 млн
Depreciation and amortization charges
5,85 млд
-
-
-
EBITDA
3,84 млд
3,41 млд
3,88 млд
6,81 млд
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer